EVG

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

Acquired Immune Deficiency Syndrome (AIDS)HIV Infections

Phase 2

Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection

CompletedNCT00445146

Gilead SciencesHIV Infections

Start: 2007-02-28End: 2015-03-31Updated: 2016-04-25

Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants

TerminatedNCT01923311

Gilead SciencesAcquired Immune Deficiency Syndrome (AIDS), HIV Infections

Start: 2013-08-26End: 2017-11-03Updated: 2018-08-09